Dapagliflozin PBS update in CKD: Expert overview

Description

In this Product Explainer, Nephrologist Prof Eugenia Pedagogos reviews the new PBS listing for dapagliflozin in chronic kidney disease, discusses clinical data, and frames the clinical implications for CKD management (5 mins).

Icon 2

NEXT LIVE Webcast

:
Days
:
Hours
:
Minutes
Seconds
Prof Andrew Sindone AM

Prof Andrew Sindone AM

MRAs for Heart Failure Update - New Developments

Prof David Price

Prof David Price

COPD Exacerbation – Inhaled steroids vs Pneumonia Risks – It's Not Black and White

A/Prof Ralph Audehm & Prof Simone Strasser

A/Prof Ralph Audehm & Prof Simone Strasser

Abnormal LFTs – Practical Cases Expert Q&A

Angela Newbound

Angela Newbound

Practical Strategies to Increase Vaccination Rates This Flu Season

Join us for the next free webcast for GPs and healthcare professionals

High quality lectures delivered by leading independent experts

Prof Eugenia Pedagogos

expert

Prof Eugenia Pedagogos

Nephrologist and Clinical Professor, University of Melbourne; Clinical Research Lead, @Home Division, Western Health; Director of Medical Services, Epworth Freemasons

Date published: 16 February 2026